Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.53 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.53 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.53 |
| ▸ | MMP8 | P22894 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8612979 | 0.92 | MMP8 (0.57) | KMT2AMMP8MMP2MMP9CTSL | |
| SCHEMBL8614468 | 0.88 | MMP8 (0.61) | PSMB1PSMB5PSMB2MMP8MMP2 | |
| SCHEMBL7806369 | 0.86 | KMT2A (0.58) | KMT2AANPEP | |
| SCHEMBL7806373 | 0.86 | KMT2A (0.58) | KMT2AANPEP | |
| SCHEMBL12310885 | 0.86 | KMT2A (0.58) | KMT2AANPEP | |
| Hydrochloric Acid SCHEMBL8617113 | 0.86 | MMP8 (0.52) | KMT2AMMP8MMP2MMP9 | |
| SCHEMBL24346074 | 0.86 | MMP8 (0.52) | MMP8CTSLCTSBCTSS | |
| SCHEMBL29591265 | 0.86 | ACE (0.54) | KMT2AMMP8CTSLCTSBCTSS | |
| Hydrochloric Acid SCHEMBL8620919 | 0.85 | CTSL (0.53) | MMP8MMP2MMP9CTSL | |
| Hydrochloric Acid SCHEMBL8617611 | 0.85 | KMT2A (0.56) | KMT2AANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2288388-B1 | ACHIEVEMENT OF HIGH THERAPEUTIC INDEX THROUGH MOLECULAR IMAGING GUIDED TARGETED DRUG TREATMENT | SIEMENS MEDICAL SOLUTIONS (US) | 2016-08-31 | — | — | EP | disclosed |
| EP-1793841-B1 | PEPTIDE INHIBITORS OF C-JUN DIMERIZATION AND USES THEREOF | PHYLOGICA LTD (AU) | 2013-04-03 | — | — | EP | disclosed |
| US-20120329720-A1 | ANTI-INFLAMMATORY COMPOUNDS AND USES THEREOF | YALE UNIVERSITY (US) | 2012-12-27 | — | — | US | disclosed |
| US-8293206-B2 | Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2012-10-23 | — | — | US | disclosed |
| US-8242240-B2 | Anti-inflammatory compounds and uses thereof | YALE UNIVERSITY (US) | 2012-08-14 | — | — | US | disclosed |
| US-8217138-B2 | Anti-inflammatory compounds and uses thereof | YALE UNIVERSITY (US) | 2012-07-10 | — | — | US | disclosed |
| US-20120101028-A1 | ANTI-INFLAMMATORY COMPOUNDS AND USES THEREOF | YALE UNIVERSITY (US) | 2012-04-26 | — | — | US | disclosed |
| EP-1448593-B1 | ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF | ALBANY MEDICAL COLLEGE (US) | 2012-01-11 | — | — | EP | disclosed |
| US-20110269692-A1 | ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF | ALBANY MEDICAL COLLEGE | 2011-11-03 | — | — | US | disclosed |
| US-8017726-B2 | Anti-inflammatory compounds and uses thereof | YALE UNIVERSITY (US) | 2011-09-13 | — | — | US | disclosed |
| US-6303567-B1 | FOR DIAGNOSIS AND THERAPY OF AMYLOIDOGENIC DISEASES SUCH AS ALZHEIMER'S DISEASE | PRAECIS PHARMACEUTICALS, INC . | 2001-10-16 | — | — | US | disclosed |
| US-6277826-B1 | CONSISTING OF D-LEUCINE, D-PHENYLALANINE AND D-VALINE; PEPTIDE IS MODIFIED AT THE AMINO-TERMINUS, THE CARBOXY-TERMINUS, OR BOTH WITH AN AMIDE OR A HYDROXY GROUP | PRAECIS PHARMACEUTICALS, INC. | 2001-08-21 | — | — | US | disclosed |
| WO-2000052048-A1 | MODULATORS OF BETA-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 2000-09-08 | — | — | WO | disclosed |
| US-5985242-A | PEPTIDE OF 3 TO 5 D-AMINO ACIDS; MAY BE MODIFIED AT AMINO-AND/OR CARBOXY TERMINUS; FOR TREATMENT OF AMYLOIDOSIS, ALZHEIMER'S DISEASE | PRAECIS PHARMACEUTICALS, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| EP-0929574-A1 | MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | Praecis Pharmaceuticals Incorporated (US) | 1999-07-21 | — | — | EP | disclosed |
| US-5854204-A | Aβ peptides that modulate β-amyloid aggregation | PRAECIS PHARMACEUTICALS, INC. (US) | 1998-12-29 | — | — | US | disclosed |
| WO-1998008868-A9 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | — | 1998-05-28 | — | — | WO | disclosed |
| WO-1998008868-A1 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 1998-03-05 | — | — | WO | disclosed |
| EP-0815134-A1 | MODULATORS OF AMYLOID AGGREGATION | Praecis Pharmaceuticals Incorporated (US) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996028471-A1 | MODULATORS OF AMYLOID AGGREGATION | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 1996-09-19 | — | — | WO | disclosed |